High Acceptability of HIV Pre-exposure Prophylaxis but Challenges in Adherence and Use: Qualitative Insights from a Phase I Trial of Intermittent and Daily PrEP in At-Risk Populations in Kenya

Elisabeth Maria Van der Elst; Judie Mbogua; Don Operario; Gaudensia Mutua; Caroline Kuo; Peter Mugo; Jennifer Kanungi; Sagri Singh; Jessica Haberer; Frances Priddy; Eduard Joachim Sanders

doi:10.1007/s10461-012-0317-8

journal article Oct 19, 2012

High Acceptability of HIV Pre-exposure Prophylaxis but Challenges in Adherence and Use: Qualitative Insights from a Phase I Trial of Intermittent and Daily PrEP in At-Risk Populations in Kenya

Elisabeth Maria Van der Elst Judie Mbogua Don Operario Gaudensia Mutua Caroline Kuo Peter Mugo Jennifer Kanungi Sagri Singh Jessica Haberer Frances Priddy

Eduard Joachim Sanders

AIDS and Behavior Vol. 17 No. 6 pp. 2162-2172 · Springer Science and Business Media LLC

View at Publisher Save 10.1007/s10461-012-0317-8

Topics

No keywords indexed for this article. Browse by subject →

References

23

[1]

Garcia-Lerma J, Otten R, Qari S, Jackson E, Cong M, Masciotra S, et al. Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir. PLoS Med. 2008;5(2):28. 10.1371/journal.pmed.0050028

[2]

Intermittent Prophylaxis with Oral Truvada Protects Macaques from Rectal SHIV Infection

J. Gerardo García-Lerma, Mian-er Cong, James Mitchell et al.

Science Translational Medicine 2010 10.1126/scitranslmed.3000391

[3]

Denton P, Estes J, Sun Z, Othieno F, Wei B, Wege A, et al. Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLoS Med. 2008;5(1):e16. 10.1371/journal.pmed.0050016

[4]

Neff C, Ndolo T, Tandon A, Habu Y, Akkina R. Oral pre-exposure prophylaxis by anti-retrovirals raltegravir and maraviroc protects against HIV-1 vaginal transmission in a humanized mouse model. PLoS One. 2010;5(12):e15257. 10.1371/journal.pone.0015257

[5]

Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

Robert M. Grant, Javier R. Lama, Peter L. Anderson et al.

New England Journal of Medicine 2010 10.1056/nejmoa1011205

[6]

Pivotal study finds that HIV medications are highly effective as prophylaxis against HIV infection in men and women in Africa. University of Washington International Clinical Research Center, Partners in PrEP Study; 2011 [cited 2011 July 30, 2011]; Available from: http://depts.washington.edu/uwicrc/research/studies/files/PrEP_PressRelease-UW_13Jul2011.pdf . Accessed 19 Sept 2012.

[7]

CDC trial and another major study find PrEP can reduce risk of HIV infection among heterosexuals. 2011 [cited 2011 July 30, 2011]; Available from: http://www.cdc.gov/nchhstp/newsroom/PrEPHeterosexuals.html . Accessed 19 Sept 2012.

[8]

Golub SA, Kowalczyk W, Weinberger CL, Parsons JT. Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. J Acquir Immune Defic Syndr. 2010;54:548–55. 10.1097/qai.0b013e3181e19a54

[9]

Mimiaga MJ, Case P, Johnson CV, Safren SA, Mayer KH. Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education. J Acquir Immune Defic Syndr. 2009;50:77–83. 10.1097/qai.0b013e31818d5a27

[10]

Galea J, Kinsler J, Salazar X, Lee S, Giron M, Sayles J, et al. Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations. Int J STD AIDS. 2011;22:256–62. 10.1258/ijsa.2009.009255

[11]

Dunkle K, Wingood G, Camp C, DiClemente R. Intention to use pre-exposure prophylaxis among African-American and white women in the United States: results from a national telephone survey. XVII International AIDS Conference; Mexico City, Mexico; 2008.

[12]

Schneider J, Dandona R, Pasupneti S, Lakshmi V, Liao C, Yeldandi V, et al. Initial commitment to pre-exposure prophylaxis and circumcision for HIV prevention amongst Indian truck drivers. PLoS One. 2010;5(7):e11922. 10.1371/journal.pone.0011922

[13]

Ware NC, Wyatt MA, Haberer JE, Baeten JM, Kintu A, Psaros C, Safren S, et al. What’s love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis (PrEP) for HIV serodiscordant couples. J Acquir Immune Defic Syndr. 2012;59(5):463–8. 10.1097/qai.0b013e31824a060b

[14]

Mutua G, Sanders E, Mugo P, Anzala O, Haberer J, Bangsberg D, et al. A randomized trial of intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men: safety and Adherence. PLoS One. 2012;7:e33103. 10.1371/journal.pone.0033103

[15]

Smith A, Muhaari A, Agwanda C, Kowuo D, van der Elst EM, Davies A. Female clients and partners of MSM sex workers in Mombasa. Paper presented at the 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA. Mombasa: CROI; 2010.

[16]

Ritchie J, Spencer L, editors. Qualitative data analysis for applied policy research. London: Routledge; 1994.

[17]

Underhill K, Operario D, Skeer M, Mimiaga M, Mayer K. Packaging PrEP to prevent HIV: an integrated framework to plan for pre-exposure prophylaxis implementation in clinical practice. J Acquir Immune Defic Syndr. 2010;55(1):8–13. 10.1097/qai.0b013e3181e8efe4

[18]

Remien RH, Stirratt JJ, Dolezal C, Dognin JS, Wagner GJ, Carballo-Dieguez A, et al. Couple-focused support to improve HIV medication adherence: a randomized controlled trial. AIDS. 2005;19:807–14. 10.1097/01.aids.0000168975.44219.45

[19]

Paxton LA, Hope T, Jaffe HW. Pre-exposure prophylaxis for HIV infection: what if it works? Lancet. 2007;370:89–93. 10.1016/s0140-6736(07)61053-8

[20]

Nozaki I, Dube C, Kakimoto K, Yamada N, Simpungwe JB. Social factors affecting ART adherence in rural settings in Zambia. AIDS Care. 2011;10:1–8. 10.1080/09540121.2010.542121

[21]

Mansergh G, Koblin B, Colfax G, McKirnan D, Flores S, Hudson S. Preefficacy use and sharing of antiretroviral medications to prevent sexually-transmitted HIV infection among US men who have sex with men. J Acquir Immune Defic Syndr. 2010;55(2):e14–6. 10.1097/qai.0b013e3181f27616

[22]

Larson E, Lin SX, Gomez-Duarte C. Antibiotic use in Hispanic households, New York City. Emerg Infect Dis. 2003;9:1096–102. 10.3201/eid0909.020371

[23]

Petersen EE, Rasmussen SA, Daniel KL, Yazdy MM, Honein MA. Prescription medication borrowing and sharing among women of reproductive age. J Womens Health. 2008;17(7):1073–80. 10.1089/jwh.2007.0769

Cited By

228

Understanding early uptake of PrEP by female sex workers in Zimbabwe

Joanna Busza, Andrew N. Phillips · 2020

AIDS Care

Metrics

228

Citations

23

References

Details

Published: Oct 19, 2012
Vol/Issue: 17(6)
Pages: 2162-2172
License: View

Authors

E

Elisabeth Maria Van der Elst

Brown University Providence RI USA

Independent Consultant , Wellington , New Zealand

E

Eduard Joachim Sanders

Cite This Article

Elisabeth Maria Van der Elst, Judie Mbogua, Don Operario, et al. (2012). High Acceptability of HIV Pre-exposure Prophylaxis but Challenges in Adherence and Use: Qualitative Insights from a Phase I Trial of Intermittent and Daily PrEP in At-Risk Populations in Kenya. AIDS and Behavior, 17(6), 2162-2172. https://doi.org/10.1007/s10461-012-0317-8

High Acceptability of HIV Pre-exposure Prophylaxis but Challenges in Adherence and Use: Qualitative Insights from a Phase I Trial of Intermittent and Daily PrEP in At-Risk Populations in Kenya

You May Also Like